Conjugated estrogens are a class of drugs derived from pregnant mare urine, primarily used for hormone replacement therapy. They are a mixture of estrogen sulfates, including estrone sulfate, equilin sulfate, and 17α-estradiol sulfate [1].
What are conjugated estrogens used for?
Conjugated estrogens are prescribed to treat moderate to severe vasomotor symptoms associated with menopause, such as hot flashes and vaginal dryness, burning, and itching. They are also used to treat hypoestrogenism resulting from ovarian failure or castration, and in the treatment of certain types of breast cancer in postmenopausal women [1]. The U.S. Food and Drug Administration (FDA) has approved various conjugated estrogen products for these indications [2].
How do conjugated estrogens work?
As a form of estrogen therapy, conjugated estrogens work by replacing the estrogen that the body stops producing during menopause. This helps to alleviate symptoms caused by estrogen deficiency. They exert their effects by binding to estrogen receptors in various tissues throughout the body [1].
What are the different types of conjugated estrogen products?
Conjugated estrogen products are available in various forms, including oral tablets, vaginal creams, vaginal inserts, and transdermal patches [1]. Examples of specific products include Premarin, which contains a mixture of water-soluble conjugated estrogens derived from natural sources, and Duavee, a combination product of conjugated estrogens and bazedoxifene used for menopausal symptoms and osteoporosis prevention [2, 3].
What are the potential risks and side effects of conjugated estrogens?
The use of estrogen therapy, including conjugated estrogens, carries certain risks. These can include an increased risk of stroke, heart attack, blood clots, and certain types of cancer, such as breast cancer and endometrial cancer, particularly when used alone without a progestin in women with a uterus. Common side effects can include nausea, headache, breast tenderness, and vaginal bleeding [1, 4].
How doesconjugated estrogen therapy compare to other menopause treatments?
Conjugated estrogens are one of the primary treatments for menopausal symptoms, but other options exist. These include non-hormonal medications, lifestyle changes, and other types of hormone therapy such as synthetic estrogens or bioidentical hormones [4]. The choice of treatment depends on individual symptoms, medical history, and patient preference.
When do patents for conjugated estrogen drugs expire?
The patent landscape for conjugated estrogen products can be complex, as multiple formulations and brand-name drugs exist. For instance, the primary active ingredient in Premarin, conjugated estrogens, has been around for a long time, and many of its original patents have expired, allowing for generic versions. However, newer combination products or delivery systems may have their own patent protections. DrugPatentWatch.com tracks patent expirations for pharmaceutical products, providing detailed information on when exclusivity for specific drugs is expected to end [5].
Can biosimilars or generics be produced for conjugated estrogen drugs?
Generic versions of some oral conjugated estrogen products are available. For biosimilar versions, the regulatory pathway is different from that of small-molecule generics. As conjugated estrogens are complex mixtures of naturally derived compounds, the development of a biosimilar or bioequivalent that meets regulatory standards is a scientific and manufacturing challenge [1, 5].